STOCK TITAN

Absci (ABSI) director buys 12,900 shares in open-market trade

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Absci Corp director Mary T. Szela made an open-market purchase of 12,900 shares of Common Stock at $11.54 per share on June 30, 2026. After this transaction, she directly owns 21,300 shares. The trade was executed in accordance with the issuer's trading policies.

Positive

  • None.

Negative

  • None.
Insider Szela Mary T
Role null
Bought 12,900 shs ($149K)
Type Security Shares Price Value
Purchase Common Stock 12,900 $11.54 $149K
Holdings After Transaction: Common Stock — 21,300 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares purchased 12,900 shares Open-market purchase on June 30, 2026
Purchase price $11.54 per share Open-market transaction for Absci Common Stock
Shares owned after 21,300 shares Direct holdings after June 30, 2026 trade
Net buy shares 12,900 shares Net buy direction in transaction summary
Buy transactions 1 transaction Open-market purchase reported in Form 4
open market purchase financial
"Open market purchase of shares in accordance with Issuer's trading policies."
An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.
Common Stock financial
"security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
trading policies financial
"Open market purchase of shares in accordance with Issuer's trading policies."
Trading policies are the written rules that govern when and how people with access to a company’s nonpublic information—such as executives, employees, or advisors—and sometimes the brokerage itself, may buy or sell the company’s securities. They matter to investors because these ‘house rules’ limit surprise sales, reduce legal and insider-trading risk, and signal how management handles market-sensitive information, which can affect share supply and investor confidence.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Szela Mary T

(Last)(First)(Middle)
C/O ABSCI CORPORATION
18105 SE MILL PLAIN BOULEVARD

(Street)
VANCOUVER WASHINGTON 98683

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Absci Corp [ ABSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026P12,900(1)A$11.5421,300D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Open market purchase of shares in accordance with Issuer's trading policies.
Remarks:
/s/ Shelby Walker, attorney-in-fact07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Absci (ABSI) report for Mary T. Szela?

Absci reported that director Mary T. Szela bought 12,900 shares of Common Stock in an open-market purchase at $11.54 per share on June 30, 2026, increasing her direct ownership to 21,300 shares after the transaction.

Was the Absci (ABSI) insider trade an open-market purchase?

Yes. The Form 4 shows Mary T. Szela completed an open-market purchase of 12,900 Absci Common Stock shares at $11.54 per share, with a footnote stating the transaction was executed in accordance with the issuer's trading policies.

How many Absci (ABSI) shares does Mary T. Szela own after this trade?

Following the June 30, 2026 transaction, Mary T. Szela directly owns 21,300 shares of Absci Common Stock. This reflects the addition of 12,900 shares purchased in the open market under the company’s trading policies as disclosed in the Form 4.

What price did Mary T. Szela pay per Absci (ABSI) share?

Mary T. Szela paid $11.54 per share for 12,900 Absci Common Stock shares in an open-market transaction on June 30, 2026, as reported in the Form 4 insider filing for this director-level purchase.

Does the Absci (ABSI) Form 4 show any insider share sales?

No insider sales are shown in this Form 4. The filing reports only one open-market purchase by director Mary T. Szela, totaling 12,900 shares bought at $11.54 per share, resulting in 21,300 shares held directly afterward.